ExozymesEXOZ
13F holders, Q2 2025 (June 30)9holders +3
3new positions
0sold out
1famous investor
$9.65avg. 13F price*
At the end of Q2 2025, 9 institutions reported holding Exozymes Inc. (EXOZ) in their 13F filings, up 3 from Q1 2025. 3 opened new positions and 0 sold out. The largest holders were Vanguard Group Inc. ($222K), Geode Capital Management, LLC ($198K) and Citadel Advisors ($174K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Exozymes Inc.
- CUSIP
- 461874109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $206K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 26,620 shares bought and 28,005 shares sold, net −1,385 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Vanguard Group Inc. | 0.00% | Reduce -54.0% | 23,154 | $222K |
| Geode Capital Management, LLC | 0.00% | Add +0.0% | 20,599 | $198K |
| Citadel Advisors | 0.00% | New | 18,144 | $174K |
| UBS Group AG | 0.00% | Add +2976.1% | 5,014 | $50K |
| BlackRock, Inc. | 0.00% | Add +8.2% | 4,841 | $48K |
| Raymond James Financial Inc. | 0.00% | New | 2,000 | $20K |
| Morgan Stanley | 0.00% | New | 1,250 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -69.6% | 344 | $3K |
| Bank of America Corp. | 0.00% | Add +16.1% | 36 | $356 |
"% of holder's portfolio" is EXOZ's weight in each manager's 13F, not the share of Exozymes Inc. the manager owns.